Cite

HARVARD Citation

    Alexander, G. et al. (n.d.). Immune biomarkers of treatment failure for a patient with renal cell carcinoma on a Phase I trial of pembrolizumab plus radiotherapy. Journal for immunotherapy of cancer. p. . [Online]. 
  
Back to record